Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early-stage young breast cancer patients: impact of local treatment on survival.
Bantema-Joppe EJ, de Munck L, Visser O, Willemse PH, Langendijk JA, Siesling S, Maduro JH. Bantema-Joppe EJ, et al. Among authors: de munck l. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e553-9. doi: 10.1016/j.ijrobp.2011.02.060. Epub 2011 Sep 9. Int J Radiat Oncol Biol Phys. 2011. PMID: 21601378 Free article.
Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
Hoogendoorn WE, Hollema H, van Boven HH, Bergman E, de Leeuw-Mantel G, Platteel I, Fles R, Nederlof PM, Mourits MJ, van Leeuwen FE; Comprehensive Cancer Centers TAMARISK-group. Hoogendoorn WE, et al. Breast Cancer Res Treat. 2008 Nov;112(1):99-108. doi: 10.1007/s10549-007-9823-1. Epub 2007 Dec 7. Breast Cancer Res Treat. 2008. PMID: 18064567
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands.
Ruiterkamp J, Ernst MF, de Munck L, van der Heiden-van der Loo M, Bastiaannet E, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VC, Voogd AC. Ruiterkamp J, et al. Among authors: de munck l. Breast Cancer Res Treat. 2011 Jul;128(2):495-503. doi: 10.1007/s10549-011-1349-x. Epub 2011 Jan 15. Breast Cancer Res Treat. 2011. PMID: 21240629
Weekly docetaxel in metastatic breast cancer patients: no superior benefits compared to three-weekly docetaxel.
Schröder CP, de Munck L, Westermann AM, Smit WM, Creemers GJ, de Graaf H, Stouthard JM, van Deijk G, Erjavec Z, van Bochove A, Vader W, Willemse PH. Schröder CP, et al. Among authors: de graaf h, de munck l. Eur J Cancer. 2011 Jun;47(9):1355-62. doi: 10.1016/j.ejca.2010.12.018. Epub 2011 Jan 19. Eur J Cancer. 2011. PMID: 21251813 Clinical Trial.
Surgical treatment of early stage breast cancer in elderly: an international comparison.
Kiderlen M, Bastiaannet E, Walsh PM, Keating NL, Schrodi S, Engel J, van de Water W, Ess SM, van Eycken L, Miranda A, de Munck L, van de Velde CJ, de Craen AJ, Liefers GJ. Kiderlen M, et al. Among authors: de craen aj, de munck l. Breast Cancer Res Treat. 2012 Apr;132(2):675-82. doi: 10.1007/s10549-011-1892-5. Epub 2011 Nov 27. Breast Cancer Res Treat. 2012. PMID: 22119939 Free PMC article.
A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study.
Reyners AKL, de Munck L, Erdkamp FLG, Smit WM, Hoekman K, Lalisang RI, de Graaf H, Wymenga ANM, Polee M, Hollema H, van Vugt MATM, Schaapveld M, Willemse PHB; DoCaCel Study Group. Reyners AKL, et al. Among authors: de graaf h, de munck l. Ann Oncol. 2012 Nov;23(11):2896-2902. doi: 10.1093/annonc/mds107. Epub 2012 Jun 11. Ann Oncol. 2012. PMID: 22689176 Free article. Clinical Trial.
81 results